LV13441B - A method for the preparation of enantiomercally pure mirtazapine - Google Patents

A method for the preparation of enantiomercally pure mirtazapine Download PDF

Info

Publication number
LV13441B
LV13441B LVP-06-21A LV060021A LV13441B LV 13441 B LV13441 B LV 13441B LV 060021 A LV060021 A LV 060021A LV 13441 B LV13441 B LV 13441B
Authority
LV
Latvia
Prior art keywords
acid
combination
solvent
compound
mirtazapine
Prior art date
Application number
LVP-06-21A
Other languages
English (en)
Latvian (lv)
Inventor
Johannes Hubertus Wieringa
De Ven Adrianus Antonius M Van
Gerardus Johannes Kemperman
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of LV13441B publication Critical patent/LV13441B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-06-21A 2003-07-10 2006-02-10 A method for the preparation of enantiomercally pure mirtazapine LV13441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10

Publications (1)

Publication Number Publication Date
LV13441B true LV13441B (en) 2006-08-20

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-06-21A LV13441B (en) 2003-07-10 2006-02-10 A method for the preparation of enantiomercally pure mirtazapine

Country Status (36)

Country Link
US (2) US8058436B2 (zh)
EP (1) EP1656365B1 (zh)
JP (1) JP4668184B2 (zh)
KR (1) KR20060056315A (zh)
CN (1) CN100558722C (zh)
AR (1) AR046494A1 (zh)
AT (1) ATE433965T1 (zh)
AU (1) AU2004255874B2 (zh)
BR (1) BRPI0412447A (zh)
CA (1) CA2531165C (zh)
CO (1) CO5640123A2 (zh)
CY (1) CY1109327T1 (zh)
DE (1) DE602004021605D1 (zh)
DK (1) DK1656365T3 (zh)
EC (1) ECSP066271A (zh)
ES (1) ES2327123T3 (zh)
HK (1) HK1086841A1 (zh)
HR (1) HRP20051019A2 (zh)
IL (1) IL172549A0 (zh)
IS (1) IS2674B (zh)
LT (1) LT5382B (zh)
LV (1) LV13441B (zh)
MX (1) MXPA06000325A (zh)
NO (1) NO20056175L (zh)
NZ (1) NZ544360A (zh)
PE (1) PE20050323A1 (zh)
PL (1) PL1656365T3 (zh)
PT (1) PT1656365E (zh)
RS (1) RS20050972A (zh)
RU (1) RU2352566C2 (zh)
SG (1) SG144914A1 (zh)
SI (1) SI1656365T1 (zh)
TW (1) TWI335915B (zh)
UA (1) UA83666C2 (zh)
WO (1) WO2005005410A1 (zh)
ZA (1) ZA200600019B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
CN102153620A (zh) * 2005-09-26 2011-08-17 住友化学株式会社 光学活性的哌嗪化合物的制造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
JP5438976B2 (ja) * 2007-02-09 2014-03-12 株式会社カネカ 光学活性２−アリールピペラジン誘導体の製造法
JP5192707B2 (ja) * 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
MX2009010967A (es) * 2007-04-11 2009-12-15 Organon Nv Un metodo para la preparacion de mirtazapina.
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
RU2048469C1 (ru) * 1989-10-05 1995-11-20 Санкио Компани Лимитед Способ получения азетидинового производного или его фармацевтически приемлемой соли
ATE289816T1 (de) 1997-11-14 2005-03-15 Akzo Nobel Nv Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
CN1679586A (zh) * 1999-04-19 2005-10-12 特瓦制药工业有限公司 含哌嗪环化合物的新型合成和结晶方法
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
AU6476300A (en) 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6474200A (en) 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
DK1257278T3 (da) 2000-02-11 2006-06-12 Akzo Nobel Nv Anvendelse af mirtazapin til behandling af sövnforstyrrelser
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
RU2006103992A (ru) 2006-06-27
US20100179319A1 (en) 2010-07-15
CA2531165A1 (en) 2005-01-20
NZ544360A (en) 2008-05-30
JP2009513537A (ja) 2009-04-02
CY1109327T1 (el) 2014-07-02
EP1656365B1 (en) 2009-06-17
EP1656365A1 (en) 2006-05-17
KR20060056315A (ko) 2006-05-24
PE20050323A1 (es) 2005-05-16
PL1656365T3 (pl) 2009-10-30
RS20050972A (en) 2008-06-05
ZA200600019B (en) 2007-01-31
AR046494A1 (es) 2005-12-14
WO2005005410A1 (en) 2005-01-20
AU2004255874B2 (en) 2010-10-28
HRP20051019A2 (en) 2006-02-28
JP4668184B2 (ja) 2011-04-13
HK1086841A1 (en) 2006-09-29
US20060229300A1 (en) 2006-10-12
TWI335915B (en) 2011-01-11
DK1656365T3 (da) 2009-09-14
IS2674B (is) 2010-09-15
PT1656365E (pt) 2009-09-01
LT5382B (lt) 2006-11-27
RU2352566C2 (ru) 2009-04-20
LT2005107A (en) 2006-06-27
SI1656365T1 (sl) 2009-10-31
UA83666C2 (ru) 2008-08-11
CN1820000A (zh) 2006-08-16
SG144914A1 (en) 2008-08-28
CO5640123A2 (es) 2006-05-31
US8058436B2 (en) 2011-11-15
AU2004255874A1 (en) 2005-01-20
BRPI0412447A (pt) 2006-09-19
IL172549A0 (en) 2006-04-10
CA2531165C (en) 2011-08-30
DE602004021605D1 (de) 2009-07-30
IS8184A (is) 2005-12-15
MXPA06000325A (es) 2006-03-30
ECSP066271A (es) 2006-07-28
ES2327123T3 (es) 2009-10-26
TW200510426A (en) 2005-03-16
CN100558722C (zh) 2009-11-11
NO20056175L (no) 2006-01-23
ATE433965T1 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
LV13441B (en) A method for the preparation of enantiomercally pure mirtazapine
US7482464B2 (en) Processes for the preparation of S-(-)-amlodipine
US20100160639A1 (en) Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
AU2009208107A1 (en) A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
US20040176460A1 (en) Process for the production of 3-phenylisoserine
MX2007014781A (es) Proceso para la resolucion dinamica de acido (r) o (s)-mandelico (substituido).
JPH0748383A (ja) 二環式ベータ−ラクタム／パラベン錯体
CN1356982A (zh) 取代哌啶－4－酮类化合物的制备
EP2146993B1 (en) A method for the preparation of mirtazapine
US5578734A (en) Method for the preparation of S-(+)-ethodolic acid and saline derivatives
US20080255348A1 (en) Method for the preparation of an enantiomer of a tetracyclic benzazepine
AU724816B2 (en) Process for the preparation of chiral, nonracemic(4-aryl-2,5-dioxoimidazolidin-1-yl)acetic acids
EP0437566A1 (en) PHENYLGLYCINE DERIVATIVES.
WO2008026838A1 (en) Method for preparing an optically active amlodipine
EP1337533B1 (en) Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
US20040110957A1 (en) Process for the synthesis of an antiviral compound
KR20000070367A (ko) (1ｓ, 4ｒ)-1-아자비시클로[2,2,1]헵탄-3-온 및 (1ｒ, 4ｓ)-1-아자비시클로[2,2,1]헵탄-3-온의 제조 방법